One hypothesis is that the secretion of these high-affinity IGFBPs increases the concentration of IGF ligands in the tumor microenvironment, which are present in an inactive form and released continuously as bioavailable ligands via the action of IGFBP proteases secreted from neoplastic cells. Here, IGF1 is linked to neoplasm.